The relentless pursuit of novel therapeutics drives innovation in pharmaceutical research, with specialized chemical intermediates playing a pivotal role. Pyrrolo[2,3-d]pyrimidin-4-ol, cataloged under CAS 3680-71-5, is one such compound that enables cutting-edge drug development. For research scientists and procurement teams, understanding its potential and sourcing it effectively is crucial.

Pyrrolo[2,3-d]pyrimidin-4-ol is recognized for its unique application as an xanthine oxidase-activated prodrug for thymidine phosphorylase inhibitors. This targeted mechanism is a testament to the sophisticated chemistry being employed in modern medicine. Its chemical structure, with the formula C6H5N3O and a high melting point (345-348ºC), makes it a stable and reliable component for complex synthesis pathways. Researchers looking to buy Pyrrolo[2,3-d]pyrimidin-4-ol should prioritize suppliers who can guarantee a minimum purity of 98%, ensuring the integrity of their research outcomes.

When planning your procurement, consider the broader supply chain. Manufacturers in China are significant contributors to the global availability of such fine chemicals. Engaging with a reputable manufacturer or supplier means obtaining not just the product, but also the assurance of consistent quality and a stable supply. This includes understanding their production capacity, packaging options (like aluminum foil bags or bottles), and delivery capabilities, whether via air, land, or sea freight.

For those in research and development, getting a quote for Pyrrolo[2,3-d]pyrimidin-4-ol is often the first step in integrating it into new projects. Suppliers who offer flexible payment terms (L/C, T/T, PayPal) and clear shipping information (Incoterms like FOB, CIF) facilitate a smoother acquisition process. The availability of this compound as a white to off-white powder, its specific CAS number, and its role in advanced drug delivery systems highlight its importance for innovative research.

In summary, Pyrrolo[2,3-d]pyrimidin-4-ol represents a key advancement in pharmaceutical research capabilities. By partnering with reliable China-based suppliers and manufacturers, research institutions can effectively secure this essential intermediate, fostering innovation and accelerating the development of next-generation medicines.